$4.760
-0.069 (-1.45%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
CSBR-Prognose durch Analyse ähnlicher Charts
Alphio's CSBR stock price prediction model matches the current Champions Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.66 (-2.16%). The 1-week path is $4.79 (+0.68%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Champions Oncology Inc-Aktien kaufen?
Champions Oncology Inc (CSBR) is currently priced at $4.81, which is near the 52-week low of $4.59. The stock has a forward P/E ratio of 22.88, indicating potential for growth, but it has experienced a significant year-to-date decline of 27.78%. The RSI is at 47.60, suggesting the stock is neither overbought nor oversold. The main risk is its negative net income trend, with a net loss of $667,000 in the last quarter, which raises concerns about profitability moving forward.
CSBR schloss am Thursday bei $4.76, nachdem der Kurs -1.45% fallen
Champions Oncology Inc (CSBR) last closed at $4.7600002, losing -1.45%. These facts feed the 1-day and 1-week CSBR price prediction above.
Analystenkonsens
Champions Oncology Inc (CSBR): 1 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Champions Oncology Inc (CSBR) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf CSBR am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für CSBR
Historically the probability of a positive November return for CSBR is 0.00%. January offers the highest probability of a positive month at 93.44%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für CSBR
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $8.15 | $8.46 | $9.50 | +77.70% |
| Dec 2026 | $6.97 | $7.86 | $7.89 | +65.11% |
Für 2026 wird für Champions Oncology Inc (CSBR) eine Spanne von $6.97 bis $9.50 projiziert.
Monatsprognose 2026 für Champions Oncology Inc
Im Nov 2026 wird für Champions Oncology Inc ein Durchschnitt von $8.46 erwartet, mit einem Tief von $8.15 und einem Hoch von $9.50.
Im Dec 2026 wird für Champions Oncology Inc ein Durchschnitt von $7.86 erwartet, mit einem Tief von $6.97 und einem Hoch von $7.89.
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.